Jakub Šimeček

⁶⁸Ga- and ¹⁷⁷Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies

Martina Weineisen, Margret Schottelius, Jakub Šimeček et al. · Journal of Nuclear Medicine · 2015 · 519 citations · Full text

Disclosing the CXCR4 Expression in Lymphoproliferative Diseases by Targeted Molecular Imaging

Hans Wester, Ulrich Keller, Margret Schottelius et al. · Theranostics · 2015 · 194 citations · Full text

Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer

Martina Weineisen, Jakub Šimeček, Margret Schottelius et al. · EJNMMI Research · 2014 · 177 citations · Full text

TRAP, a Powerful and Versatile Framework for Gallium‐68 Radiopharmaceuticals

Johannes Notni, Jakub Šimeček, Petr Hermann et al. · Chemistry - A European Journal · 2011 · 157 citations

Positron Emission Tomography, Engineering, Biochemistry +13

Complexation of Metal Ions with TRAP (1,4,7-Triazacyclononane Phosphinic Acid) Ligands and 1,4,7-Triazacyclononane-1,4,7-triacetic Acid: Phosphinate-Containing Ligands as Unique Chelators for Trivalent Gallium

Jakub Šimeček, Martin Schulz, Johannes Notni et al. · Inorganic Chemistry · 2011 · 110 citations